Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences


Featured Articles

Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification

Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies

James Barry, Director of Marketing, Americas, Pall Biotech

Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma

Scheduling and Optimization of Biomanufacturing Activities in Multi-product Facilities with Disposable Technologies

Gloria Gadea-Lopez, Ph.D. is Director of Production and Business Systems at the Shire Lexington, John Maguireis the Associate Director of Manufacturing Systems at Shire’s Lexington and Megan Rabideau is a Manufacturing Systems Engineer at Shire’s Lexington

View All Featured Articles

Headline News

FDA expands CAMZYOS approval to paediatric patients with obstructive hypertrophic cardiomyopathy


Foundayo linked to lower predicted long term diabetes and cardiovascular risk in ATTAIN 1 analysis


ABBV 295 shows extended half life and weight loss in Phase I obesity study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Characterization of Residual Impurities in Gene Therapy Drug Products

Presented by Jessica Townsend, Senior Manager Analytical Development at bluebird bio and Eric S. Bishop, Vice President of Research & Development at Cygnus Technologies
26th January 2023


Next Generation Bioprocess Facility Design – A Case Study From Samsung Biologics

Presented by Ken Green, Ph.D, Head of Manufacturing, Science and Technology at Samsung Biologics and John Bonham-Carter. Product Line Leader, Cell Culture & Clarification Business, Repligen
26th October 2020


Analysing Complex Data in the Pharmaceutical Industry: The Case for Multivariate Analysis

Presented by Presented by Mike Tobyn, Research Fellow at Bristol-Myers Squibb
02nd May 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia